Zentalis Pharmaceuticals: A Cautious Hold Amidst Speculative Opportunities and Upcoming Clinical Updates
TipRanksMar 1 01:04 ET
HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $46 Price Target
BenzingaFeb 28 12:50 ET
Zentalis Pharma Analyst Ratings
BenzingaFeb 28 07:59 ET
Oppenheimer Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)
TipRanksFeb 28 07:47 ET
Buy Rating Affirmed for Zentalis Pharmaceuticals on Strategic Positioning and Clinical Prospects in Ovarian Cancer Treatment
TipRanksFeb 28 06:38 ET
Buy Rating on Zentalis Pharmaceuticals Amidst Undervalued Share Price and Promising Clinical Developments
TipRanksFeb 28 05:43 ET
TD Cowen Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)
TipRanksFeb 27 13:25 ET
Zentalis Pharmaceuticals (ZNTL) Receives a Buy From Stifel Nicolaus
TipRanksNov 30, 2023 07:26 ET
UBS Adjusts Zentalis Pharmaceuticals Price Target to $28 From $52, Maintains Buy Rating
MT NewswiresNov 28, 2023 10:37 ET
Wedbush Cuts Zentalis to Neutral, Cites Strategy Shift for Ovarian Cancer Drug
Seeking AlphaNov 8, 2023 11:58 ET
Zentalis Hits 52-week Low as Leerink Downgrades on Data for Lead Asset
Seeking AlphaNov 7, 2023 14:36 ET
Stifel Cuts Price Target on Zentalis Pharmaceuticals to $36 From $44, Maintains Buy Rating
MT NewswiresNov 7, 2023 10:21 ET
Akash Tewari's Buy Rating on Zentalis Pharmaceuticals: Analysis of Q3 Results and Future Outlook
TipRanksNov 7, 2023 08:26 ET
HC Wainwright & Co. Maintains Buy on Zentalis Pharma, Lowers Price Target to $46
BenzingaNov 7, 2023 08:18 ET
Zentalis Pharma Analyst Ratings
BenzingaNov 7, 2023 08:17 ET
Promising Clinical Data and Strategic Adaptability Bolster Buy Rating for Zentalis Pharmaceuticals: An Analysis of Michael Ulz's Recommendation
TipRanksNov 7, 2023 06:31 ET
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL) and Humana (HUM)
TipRanksNov 7, 2023 05:10 ET
Stifel Nicolaus Sticks to Its Buy Rating for Zentalis Pharmaceuticals (ZNTL)
TipRanksAug 13, 2023 22:05 ET
Wells Fargo Maintains Overweight on Zentalis Pharma, Lowers Price Target to $50
BenzingaAug 10, 2023 10:05 ET
HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $55 Price Target
BenzingaAug 10, 2023 06:40 ET
No Data
No Data